have you all forgotten about the Feuerestein-Dr. Ratain rule. if not please google it and you will see Adam's take on biotechs possibility of getting approved. One of the approval markers is the company being valued above 300 million several months before FDA meeting. Clearly POZN does not meet that marker. so i will stay out of this stock and recommend we all follow the Feuerstein-Ratain rule..
Adam Feuerestein . Your kidding . Last i heard he was still busy wiping all that egg off his bald head after the decision on MNKD. POZN has a possible blockbuster product here and almost certain approval LOL.